Drug Database
Back to search

Netherlands· NL-b3afd8d0b1e2

Ovitrelle 250 microgram/0,5 ml, oplossing voor injectie in een voorgevulde spuit

A chorionic gonadotrophin product containing choriogonadotropine alfa, registered in Netherlands by Merck Europe B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC G03GA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedOvitrelle 250 microgram/0,5 ml, oplos…ATCG03GA01REGISTER NO.NL-b3afd8d0b1e2PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about choriogonadotropine alfaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Chorionic gonadotrophin is registered in 12 of 19 countries.

Countries holding a registration under ATC G03GA01 (chorionic gonadotrophin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search chorionic gonadotrophin products by name

Chorionic gonadotrophin · ATC G03GA01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CHORIOGONADOTROPINE ALFA
Manufacturer
Merck Europe B.V.
Country
Netherlands (NL)
ATC code
G03GA01
ATC class
Chorionic gonadotrophin
Defined daily dose
7.5 TSD, E
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/00/165

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for chorionic gonadotrophin.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check chorionic gonadotrophin against other medicinesHow interaction checks work

Chorionic gonadotrophin · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • GanirelixH01CC01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chorionic gonadotrophin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chorionic gonadotrophin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Ovitrelle
  • Liechtenstein · Ovitrelle
  • Norway · Ovitrelle

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/92e39801-e6cb-42b7-ba5e-93ac4509c43a
GET /v1/drugs/92e39801-e6cb-42b7-ba5e-93ac4509c43a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Subcutaan gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ovitrelle-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Chorionic Gonadotropin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp71801",
  "excipients": [
    "FOSFORZUUR (E 338)",
    "MANNITOL (D-) (E 421)",
    "METHIONINE, (L-)",
    "NATRIUMHYDROXIDE (E 524)",
    "POLOXAMEER 188",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "CHORIOGONADOTROPINE ALFA"
  ],
  "leaflet_url": null,
  "authorised_at": "2003/10/24",
  "procedure_number": "EMEA/H/C/000320",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/00/165",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about chorionic gonadotrophin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console